Remove 2016 Remove Clinical Trials Remove Concentrates Remove Environment
article thumbnail

MediPharm Labs Enters into Agreements with Australian Licensed Producer & Forms Multiple Cannabis Supply Partnerships to Advance Australian Market Leadership

Cannabis Law Report

The state-of-the-art facility will feature supercritical CO 2 extraction capacity to process up to 75,000 kg of dried cannabis annually as well secondary processing equipment for the manufacture of purified and high-concentrate cannabis distillate. Australian Leadership Appointments. in Australia earlier this year. About MediPharm Labs.

article thumbnail

Study: CBD “Promising” Therapy for Cocaine Addiction

CannaMD

Note: No human studies were found (with the exception of one clinical trial that was ongoing and therefore not selected); all studies focused on animals (i.e., We found that CBD impaired the reconsolidation of preference for the environment previously paired with both morphine and cocaine. [T]hese mice/rats). Hepatic protection.

Therapy 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ElleVet Sciences Publishes Safety Study On CBD For Animals

Cannabis Law Report

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety 45
article thumbnail

Outline – Hopgood & Ganim Lawyers: Medicinal Cannabis in Australia: issues and regulations

Cannabis Law Report

Through the Narcotic Drugs Amendment Act 2016 (Cth) and its amendments to the Narcotic Drugs Act 1967 (Cth) ( NDA ), the Australian Government commenced the legalisation of medicinal cannabis products in Australia under federal law in 2016. Josh Hunt – Partner. Callum Twigger – Lawyer.